Endometria from Obese PCOS Women with Hyperinsulinemia Exhibit Altered Adiponectin Signaling

Abstract

Hyperandrogenemia, hyperinsulinemia, and obesity affect 60–70% of patients with Polycystic Ovarian Syndrome (PCOS), who exhibit an altered endometrial insulin signaling. The aim of the study was to evaluate whether hyperandrogenism, hyperinsulinism, and obesity present in PCOS patients impair the endometrial adiponectin signaling pathway. The ex vivo study was conducted on 27 samples from lean (n=9), obese (n=9), and obese-PCOS (n=9) patients. The in vitro assays were performed in immortalized human endometrial stromal cells stimulated with testosterone, insulin, or testosterone plus insulin. Serum steroid-hormones, adiponectin, glucose, and insulin; body mass index, free androgen index, ISI-Composite, and HOMA were evaluated in the 3 groups. Ex vivo and in vitro gene expression and protein content of adiponectin, AdipoR1, AdipoR2, and APPL1 were determined. Adiponectin serum levels were decreased in obese-PCOS patients compared to lean (78%) and obese (54%) controls (p<0.05). AdipoR1 protein and gene expression were increased in obese group vs. obese-PCOS and lean groups (2-fold, p<0.05). In turn, AdipoR2 protein and mRNA content was similar between the 3 groups. APPL1 protein levels were reduced in endometria from both obese groups, compared to lean group (6-fold, p<0.05). Testosterone plus insulin stimulation of T-HESC and St-T1b leads to a reduction of adiponectin, AdipoR1, AdipoR2, and APPL1 protein content in both endometrial cell lines (p<0.05), whereas, in the presence of testosterone or insulin alone, protein levels were similar to basal. Therefore, endometrial adiponectin-signaling pathway is impaired in hyperandrogenemic and hyperinsulinemic obese-PCOS patients, corroborated in the in vitro model, which could affect endometrial function and potentially the implantation process.

Key words

adipokine - adiponectin receptors - APPL1 - hyperandrogenemia

• References

• 1 Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Rec Prog Horm Res 1998; 53: 217-256
• 2 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
• 3 Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 237-245
• 4 Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012; 33: 981-1030
• 5 Quezada S, Avellaira C, Johnson MC, Gabler F, Fuentes A, Vega M. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85: 1017-1026
• 6 Villavicencio A, Bacallao K, Avellaira C, Gabler F, Fuentes A, Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol 2006; 103: 307-314
• 7 Frolova AI, Moley KH. Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles. Reproduction 2011; 142: 211-220
• 8 Fornés R, Ormazabal P, Rosas C, Gabler F, Vantman D, Romero C, Vega M. Changes in the expresión of insulin signaling pathway molecules in endometria from PCOS women with or without insulin resistance. Mol Med 2010; 16: 129-136
• 9 Rosas C, Gabler F, Vantman D, Romero C, Vega M. Levels of Rabs and WAVE family proteins associated to translocation of GLUT4 to the cell surface in endometria from control and hyperinsulinemic PCOS women. Human Reprod 2010; 25: 2870-2877
• 10 Rivero R, Garin C, Ormazabal P, Silva A, Carvajal R, Gabler F, Romero C, Vega M. Protein expression of PKCZ (protein kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS). Reprod Biol Endocrinol 2012; 10: 17
• 11 Kohan K, Carvajal R, Gabler F, Vantman D, Romero C, Vega M. Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome. Reproduction 2010; 140: 123-131
• 12 Carvajal R, Rosas C, Kohan K, Gabler F, Vantman D, Romero C, Vega M. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Human Reproduction 2013; 28: 2235-2244
• 13 Schulte MMB, Tsai JH, Moley KH. Obesity and PCOS: The Effect of Metabolic Derangements on Endometrial Receptivity at the Time of Implantation. Reprod Sci 2015; 22: 6-14
• 14 Guerre-Millo M. Adiponectin: an update. Diabetes Metab 2008; 34: 12-18
• 15 Passos MCF. Gonçalves MC. Regulation of Insulin Sensitivity by Adiponectin and its Receptors in Response to Physical Exercise. Horm Metab Res 2014; 46: 603-608
• 16 Takemura Y, Osuga Y, Yamauchi T, Kobayashi M, Harada M, Hirata T, Morimoto C, Hirota Y, Yoshino O, Koga K, Yano T, Kadowaki T, Taketani Y. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 2006; 147: 3203-3210
• 17 Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009; 15: 297-307
• 18 Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, Liu F, Dong LQ. APPL1 binds to adiponectin receptors and mediates adiponectin signaling and function. Nat Cell Biol 2006; 8: 516-523
• 19 Deepa SS, Dong LQ. APPL1: role of adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009; 296: E22-E36
• 20 Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction 2005; 130: 583-597
• 21 Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 3-25
• 22 Maliqueo M, Clementi M, Gabler F. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic. Fertil Steril 2003; 80: 812-819
• 23 McAuley K, Mann J, Chase J, Lotz T, Shaw G. Point: HOMA – Satisfactory for the Time. Diabetes Care 2007; 30: 2411-2413
• 24 DeFronzo R, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010; 33: e93
• 25 Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, Rahman M, Caze R, Qumsiyeh M, Lockwwood CJ. A Novel Immortalized Human Endometrial Stromal Cell Line with Normal Progestational Response. Endocrinology 2004; 145: 2291-2296
• 26 Samalecos A, Reimann K, Wittmann S, Schulte HM, Brosens JJ, Bamberger AM, Gellersen B. Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1b. Reprod Biol Endocrinol 2009; 7: 76
• 27 Ormazabal P, Romero C, Quest AFG, Vega M. Testosterone Modulates the Expression of Molecules Linked to Insulin Action and Glucose Uptake in Endometrial Cells. Horm Metab Res 2013; 45: 1-6
• 28 Yildiz B, Knochenhauer E, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 162-168
• 29 Michalakis KG, Segars JH. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction. Fertil Steril 2010; 94: 1949-1957
• 30 Angelidis G, Dafopoulos K, Messini CI, Valotassiou V, Tsikouras P, Vrachnis N, Psimadas D, Georgoulias P, Messinis IE. The emerging roles of adiponectin in female reproductive system-associated disorders and pregnancy. Reprod Sci 2013; 20: 872-881
• 31 Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-180
• 32 Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003; 26: 2383-2388
• 33 O’Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010; 95: 1378-1385
• 34 Sir-Petermann T, Echiburú B, Maliqueo M, Crisosto N, Sánchez F, Hitschfeld C, Cárcamo M, Amigo P, Pérez-Bravo F. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Human Reprod 2007; 22: 1830-1836
• 35 Mirza SS, Shafique K, Shaikh AR, Khan NA, Anwar Qureshi M. Association between circulating adiponectin levels and polycystic ovarian syndrome. J Ovar Res 2014; 7: 18
• 36 Avellaira C, Villavicencio A, Bacallao K, Gabler F, Wells P, Romero C, Vega M. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome. Human Reprod 2006; 21: 3116-3121
• 37 Bacallao K, Leon L, Gabler F, Soto E, Romero C, Valladares L, Vega M. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia. J Steroid Biochem Mol Biol 2008; 110: 163-169
• 38 Pangaribuan B, Yusuf I, Mansyur M, Wijaya A. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther Adv Endocrinol Metab 2011; 2: 235-45
• 39 Lacerte G, Langlois MF, Doyon M, Brown C, Carpentier AC, Hivert MF. Differential Impact of Changes in Adiposity Distribution on Insulin Resistance and Adiponectin Variations Over 4 Years in Normal Weight Young Adults. Horm Metab Res 2014; 46: 354-359
• 40 Chazenbalk G, Trivax B, Yildiz B, Bertolotto C, Mathur R, Heneidi S, Azziz R. Regulation of Adiponectin Secretion by Adipocytes in the Polycystic Ovary Syndrome: Role of Tumor Necrosis Factor-α. J Clin Endocrinol Metab 2010; 95: 935-942
• 41 Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab 2012; 97: 2231-2242
• 42 Civitarese E, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, Berria R, Belfort R, DeFronzo R, Mandarino L, Ravussin E. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004; 7: 816-820
• 43 Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451
• 44 Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction 2005; 130: 583-597
• 45 Dos Santos E, Serazin V, Morvan C, Torre A, Wainer R, de Mazancourt P, Dieudonné MN. Adiponectin and leptin systems in human endometrium during window of implantation. Fertil Steril 2012; 97: 771-778
• 46 Marinho R, Ropelle ER, Cintra DE, De Souza CT, Da Silva AS, Bertoli FC, Colantonio E, D’Almeida V, Pauli JR. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. J Cell Physiol 2012; 227: 2917-2926
• 47 Cheng KKY, Lam KSL, Wang Y, Huang Y, Carling D, Wu D, Wong C, Xu A. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007; 56: 1387-1394
• 48 Cheng KK, Lam KS, Wu D, Wang Y, Sweeney G, Hoo RL, Zhang J, Xu A. APPL1 potentiates insulin secretion in pancreatic β cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice. Proc Natl Acad Sci USA 2012; 109: 8919-8924
• 49 Holmes RM, Yi Z, De Filippis E, Berria R, Shahani S, Sathyanarayana P, Sherman V, Fujiwara K, Meyer C, Christ-Roberts C, Hwang H, Finlayson J, Dong LQ, Mandarino LJ, Bajaj M. Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling. Diabetologia 2011; 54: 2122-2131
• 50 Patel SA, Hoehn KL, Lawrence RT, Sawbridge L, Talbot NA, Tomsig JL, Turner N, Cooney GJ, Whitehead JP, Kraegen EW, Cleasby ME. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. Endocrinology 2012; 153: 5231-5246